As the expression level and activity of FoxO1 are significantly increased in the liver tissues of patients with severe fatty liver disease and type 2 diabetes mellitus, FoxO1 has an important role in the occurrence and progression of human metabolic syndrome [37–40]. The gene discussed is FOXO1; the disease is type 2 diabetes mellitus.